Impact of respiratory treatment with bronchodilators on pulmonary function, mental health, and health-related behaviors in COPD patients

Authors

  • E.Samantha Author
  • B.Kalpanadevi Author
  • S.Umarani Author
  • Kethavath Roja Author

Keywords:

COPD, respiratory treatment, Symbicor, Budegopher, negative attitude, healthy conduct

Abstract

The aim of this study is to examine the impact of administering bronchodilators in conjunction with respiratory treatment on the health
behavior, psychological state, and pulmonary function of individuals suffering from Chronic Obstructive Pulmonary Disease (COPD).
Method: Between January 2021 and January 2023, 90 COPD patients were treated at the First People's Hospital in Fuyang, Hangzhou,
China. This data was analyzed retrospectively. Three groups of patients were assigned: 26 patients received budegopher, 28 patients
received symbicor, and 36 patients received both budegopher and respiratory care in combination. Lung function, psychological status (as
measured by the Health Behavior Scale (HPL), the Self-Rating Depression Scale (SDS), and the Self-Rating Anxiety Scale (SAS) were
noted.
Results: Following therapy, there were notable variations in the three groups' forced vital capacity (FVC) and forced expiratory volume
in one second (FEV1). The symbicor group outperformed the budegopher group in terms of outcomes, while the combination group
outperformed both the budegopher and symbicor groups in terms of improvement (p < 0.001). Group differences were found in pairwise
comparisons of health behavior (HPL) and psychological state (SAS and SDS). There were modest positive relationships between healthpromoting activities (HPL) and lung function indicators (FEV1, FVC) and negative connections with unfavorable psychological attitudes
(SAS, SDS). Health-promoting activities (HPL) and negative psychological attitudes (SAS, SDS) had a somewhat unfavorable correlation.
In summary: Bronchodilator therapy in conjunction with respiratory treatment has significant promise in improving lung function,
reducing depressive symptoms, encouraging healthy lifestyle choices, and hastening the recuperation of COPD patients. Nonetheless,
there can be minute differences in the medicinal effects of various medications, necessitating further research.

Downloads

Published

2021-11-17

How to Cite

Impact of respiratory treatment with bronchodilators on pulmonary function, mental health, and health-related behaviors in COPD patients. (2021). International Journal of Life Sciences Biotechnology and Pharma Sciences, 17(4), 11-17. https://ijlbps.net/index.php/ijlbps/article/view/123

Similar Articles

11-20 of 43

You may also start an advanced similarity search for this article.